Annual Accounts Payable
$1.59 B
+$18.00 M+1.15%
31 December 2023
Summary:
Amgen annual accounts payable is currently $1.59 billion, with the most recent change of +$18.00 million (+1.15%) on 31 December 2023. During the last 3 years, it has risen by +$169.00 million (+11.89%). AMGN annual accounts payable is now at all-time high.AMGN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.15 B
-$120.00 M-5.29%
30 September 2024
Summary:
Amgen quarterly accounts payable is currently $2.15 billion, with the most recent change of -$120.00 million (-5.29%) on 30 September 2024. Over the past year, it has increased by +$789.00 million (+58.10%). AMGN quarterly accounts payable is now -5.29% below its all-time high of $2.27 billion, reached on 30 June 2024.AMGN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMGN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | +58.1% |
| 3 y3 years | +11.9% | +83.3% |
| 5 y5 years | +31.7% | +113.6% |
AMGN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +16.4% | -5.3% | +83.3% |
| 5 y | 5 years | at high | +31.7% | -5.3% | +113.6% |
| alltime | all time | at high | >+9999.0% | -5.3% | >+9999.0% |
Amgen Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.15 B(-5.3%) |
| June 2024 | - | $2.27 B(+39.3%) |
| Mar 2024 | - | $1.63 B(+2.4%) |
| Dec 2023 | $1.59 B(+1.1%) | $1.59 B(+17.1%) |
| Sept 2023 | - | $1.36 B(+12.0%) |
| June 2023 | - | $1.21 B(-8.2%) |
| Mar 2023 | - | $1.32 B(-16.0%) |
| Dec 2022 | $1.57 B(+15.1%) | $1.57 B(+30.6%) |
| Sept 2022 | - | $1.20 B(-4.1%) |
| June 2022 | - | $1.26 B(-10.5%) |
| Mar 2022 | - | $1.40 B(+2.7%) |
| Dec 2021 | $1.37 B(-3.9%) | $1.37 B(+16.7%) |
| Sept 2021 | - | $1.17 B(-8.3%) |
| June 2021 | - | $1.28 B(-8.5%) |
| Mar 2021 | - | $1.40 B(-1.8%) |
| Dec 2020 | $1.42 B(+3.6%) | $1.42 B(+22.4%) |
| Sept 2020 | - | $1.16 B(+1.0%) |
| June 2020 | - | $1.15 B(-14.1%) |
| Mar 2020 | - | $1.34 B(-2.4%) |
| Dec 2019 | $1.37 B(+13.6%) | $1.37 B(+36.4%) |
| Sept 2019 | - | $1.00 B(+0.4%) |
| June 2019 | - | $1.00 B(-8.2%) |
| Mar 2019 | - | $1.09 B(-9.6%) |
| Dec 2018 | $1.21 B(-10.7%) | $1.21 B(+15.8%) |
| Sept 2018 | - | $1.04 B(+1.6%) |
| June 2018 | - | $1.03 B(-5.8%) |
| Mar 2018 | - | $1.09 B(-19.5%) |
| Dec 2017 | $1.35 B(+47.4%) | $1.35 B(+53.8%) |
| Sept 2017 | - | $879.00 M(-0.5%) |
| June 2017 | - | $883.00 M(-2.1%) |
| Mar 2017 | - | $902.00 M(-1.6%) |
| Dec 2016 | $917.00 M(-5.0%) | $917.00 M(+11.2%) |
| Sept 2016 | - | $825.00 M(-5.2%) |
| June 2016 | - | $870.00 M(+6.4%) |
| Mar 2016 | - | $818.00 M(-15.2%) |
| Dec 2015 | $965.00 M(-3.0%) | $965.00 M(-9.6%) |
| Sept 2015 | - | $1.07 B(+14.2%) |
| June 2015 | - | $934.00 M(+5.2%) |
| Mar 2015 | - | $888.00 M(-10.8%) |
| Dec 2014 | $995.00 M(+26.4%) | $995.00 M(+4.2%) |
| Sept 2014 | - | $955.00 M(-2.7%) |
| June 2014 | - | $982.00 M(+3.5%) |
| Mar 2014 | - | $949.00 M(+20.6%) |
| Dec 2013 | $787.00 M(-13.0%) | $787.00 M(-12.1%) |
| Sept 2013 | - | $895.00 M(-11.0%) |
| June 2013 | - | $1.01 B(+7.0%) |
| Mar 2013 | - | $940.00 M(+3.9%) |
| Dec 2012 | $905.00 M(+41.0%) | $905.00 M(+3.1%) |
| Sept 2012 | - | $878.00 M(-0.7%) |
| June 2012 | - | $884.00 M(-0.8%) |
| Mar 2012 | - | $891.00 M(+38.8%) |
| Dec 2011 | $642.00 M(-10.3%) | $642.00 M(-12.5%) |
| Sept 2011 | - | $734.00 M(-15.6%) |
| June 2011 | - | $870.00 M(+4.6%) |
| Mar 2011 | - | $832.00 M(+16.2%) |
| Dec 2010 | $716.00 M(+24.7%) | $716.00 M(-0.8%) |
| June 2010 | - | $722.00 M(-18.1%) |
| Mar 2010 | - | $882.00 M(+53.7%) |
| Dec 2009 | $574.00 M(+13.9%) | $574.00 M(-6.4%) |
| Sept 2009 | - | $613.00 M(-3.5%) |
| June 2009 | - | $635.00 M(-7.6%) |
| Mar 2009 | - | $687.00 M(+36.3%) |
| Dec 2008 | $504.00 M(+33.3%) | $504.00 M(-6.3%) |
| Sept 2008 | - | $538.00 M(-29.6%) |
| June 2008 | - | $764.00 M(+46.4%) |
| Mar 2008 | - | $522.00 M(+38.1%) |
| Dec 2007 | $378.00 M(-31.9%) | $378.00 M(-13.7%) |
| Sept 2007 | - | $438.00 M(-19.2%) |
| June 2007 | - | $542.00 M(-9.8%) |
| Mar 2007 | - | $601.00 M(+8.3%) |
| Dec 2006 | $555.00 M | $555.00 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $569.00 M(-14.8%) |
| June 2006 | - | $668.00 M(+51.1%) |
| Mar 2006 | - | $442.00 M(-25.8%) |
| Dec 2005 | $596.00 M(+17.6%) | $596.00 M(+19.9%) |
| Sept 2005 | - | $497.00 M(-1.2%) |
| June 2005 | - | $503.00 M(-8.4%) |
| Mar 2005 | - | $549.00 M(+8.3%) |
| Dec 2004 | $507.00 M(+55.0%) | $507.00 M(+50.4%) |
| Sept 2004 | - | $337.00 M(+8.0%) |
| June 2004 | - | $311.90 M(+0.3%) |
| Mar 2004 | - | $311.00 M(-4.9%) |
| Dec 2003 | $327.00 M(+28.2%) | $327.00 M(+29.0%) |
| Sept 2003 | - | $253.40 M(-6.1%) |
| June 2003 | - | $270.00 M(-7.5%) |
| Mar 2003 | - | $291.80 M(+14.4%) |
| Dec 2002 | $255.00 M(+86.5%) | $255.00 M(+29.0%) |
| Sept 2002 | - | $197.70 M(+49.3%) |
| June 2002 | - | $132.40 M(+24.8%) |
| Mar 2002 | - | $106.10 M(-22.4%) |
| Dec 2001 | $136.70 M(-4.5%) | $136.70 M(+94.5%) |
| Sept 2001 | - | $70.30 M(-27.9%) |
| June 2001 | - | $97.50 M(+0.6%) |
| Mar 2001 | - | $96.90 M(-32.3%) |
| Dec 2000 | $143.20 M(+71.7%) | $143.20 M(+17.8%) |
| Sept 2000 | - | $121.60 M(+1.2%) |
| June 2000 | - | $120.10 M(+10.5%) |
| Mar 2000 | - | $108.70 M(+30.3%) |
| Dec 1999 | $83.40 M(-31.4%) | $83.40 M(-17.3%) |
| Sept 1999 | - | $100.80 M(-30.0%) |
| June 1999 | - | $144.00 M(+51.4%) |
| Mar 1999 | - | $95.10 M(-21.8%) |
| Dec 1998 | $121.60 M(+17.0%) | $121.60 M(+39.3%) |
| Sept 1998 | - | $87.30 M(+2.7%) |
| June 1998 | - | $85.00 M(-26.0%) |
| Mar 1998 | - | $114.80 M(+10.5%) |
| Dec 1997 | $103.90 M(+38.5%) | $103.90 M(+45.3%) |
| Sept 1997 | - | $71.50 M(-13.4%) |
| June 1997 | - | $82.60 M(+7.8%) |
| Mar 1997 | - | $76.60 M(+2.1%) |
| Dec 1996 | $75.00 M(+37.9%) | $75.00 M(+79.9%) |
| Sept 1996 | - | $41.70 M(-21.3%) |
| June 1996 | - | $53.00 M(+65.6%) |
| Mar 1996 | - | $32.00 M(-41.2%) |
| Dec 1995 | $54.40 M(+78.4%) | $54.40 M(+15.3%) |
| Sept 1995 | - | $47.20 M(+23.9%) |
| June 1995 | - | $38.10 M(+13.7%) |
| Mar 1995 | - | $33.50 M(+9.8%) |
| Dec 1994 | $30.50 M(+32.0%) | $30.50 M(+39.3%) |
| Sept 1994 | - | $21.90 M(+28.8%) |
| June 1994 | - | $17.00 M(-17.9%) |
| Mar 1994 | - | $20.70 M(-10.4%) |
| Dec 1993 | $23.10 M(-39.2%) | $23.10 M(+9.5%) |
| Sept 1993 | - | $21.10 M(-21.3%) |
| June 1993 | - | $26.80 M(+16.0%) |
| Mar 1993 | - | $23.10 M(-39.2%) |
| Dec 1992 | $38.00 M(+28.8%) | $38.00 M(+59.0%) |
| Sept 1992 | - | $23.90 M(-2.4%) |
| June 1992 | - | $24.50 M(-0.8%) |
| Mar 1992 | - | $24.70 M(-16.3%) |
| Dec 1991 | $29.50 M(+48.2%) | $29.50 M(+150.0%) |
| Sept 1991 | - | $11.80 M(-19.2%) |
| June 1991 | - | $14.60 M(-26.6%) |
| Mar 1991 | - | $19.90 M(+168.9%) |
| Mar 1991 | $19.90 M(+65.8%) | - |
| Dec 1990 | - | $7.40 M(-21.3%) |
| Sept 1990 | - | $9.40 M(+74.1%) |
| June 1990 | - | $5.40 M(-55.0%) |
| Mar 1990 | $12.00 M(+41.2%) | $12.00 M(+76.5%) |
| Dec 1989 | - | $6.80 M(+51.1%) |
| Sept 1989 | - | $4.50 M(-28.6%) |
| June 1989 | - | $6.30 M(-25.9%) |
| Mar 1989 | $8.50 M | $8.50 M |
FAQ
- What is Amgen annual accounts payable?
- What is the all time high annual accounts payable for Amgen?
- What is Amgen annual accounts payable year-on-year change?
- What is Amgen quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amgen?
- What is Amgen quarterly accounts payable year-on-year change?
What is Amgen annual accounts payable?
The current annual accounts payable of AMGN is $1.59 B
What is the all time high annual accounts payable for Amgen?
Amgen all-time high annual accounts payable is $1.59 B
What is Amgen annual accounts payable year-on-year change?
Over the past year, AMGN annual accounts payable has changed by +$18.00 M (+1.15%)
What is Amgen quarterly accounts payable?
The current quarterly accounts payable of AMGN is $2.15 B
What is the all time high quarterly accounts payable for Amgen?
Amgen all-time high quarterly accounts payable is $2.27 B
What is Amgen quarterly accounts payable year-on-year change?
Over the past year, AMGN quarterly accounts payable has changed by +$789.00 M (+58.10%)